Champions Oncology Q4 2024 Adj EPS $0.01 Beats $(0.16) Estimate, Sales $14.001M Beat $12.692M Estimate
Champions Oncology Q4 2024 Adj EPS $0.01 Beats $(0.16) Estimate, Sales $14.001M Beat $12.692M Estimate
champions oncology 2024年第四季每股收益$0.01，超过$(0.16)的预期，销售额为1.4亿美元，超过预期的1.2692亿美元。
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.16) by 106.25 percent. This is a 105.88 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $14.001 million which beat the analyst consensus estimate of $12.692 million by 10.31 percent. This is a 7.11 percent increase over sales of $13.071 million the same period last year.
Champions Oncology（纳斯达克：CSBR）报告每股收益为0.01美元，超过分析师预期的（0.16）美元，增长106.25％。这比去年同期每股亏损（0.17）美元增长105.88％。公司报告的季度销售额为1400.1万美元，比分析师预期的1269.2万美元增长10.31％。这是去年同期1307.1万美元销售额的7.11％增长。